Galiellalactone
Galiellalactone is a is a small non-toxic and non-mutagenic fungal metabolite, a selective inhibitor of STAT3 signaling, with an IC50 of 250-500 nM. Galiellalactone can be used to research castration-resistant prostate cancer.
For research use only. We do not sell to patients.
- CAS No.: 133613-71-5
- Formula: C11H14O3
- Molecular Weight:194.23
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
|
STAT3 250-500 nM (IC50) |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| BT-549 | IC50 |
12.68 μM
Compound: 1
|
Cytotoxic activity against human BT549 cells incubated for 24 hrs by MTT assay
Cytotoxic activity against human BT549 cells incubated for 24 hrs by MTT assay
|
[PMID: 28705432] |
| DU-145 | IC50 |
3.02 μM
Compound: 1
|
Antiproliferative activity against human DU145 cells after 72 hrs by WST-1 proliferation assay
Antiproliferative activity against human DU145 cells after 72 hrs by WST-1 proliferation assay
|
[PMID: 27111731] |
| MDA-MB-231 | IC50 |
16.93 μM
Compound: 1
|
Cytotoxic activity against human MDA-MB-231 cells incubated for 24 hrs by MTT assay
Cytotoxic activity against human MDA-MB-231 cells incubated for 24 hrs by MTT assay
|
[PMID: 28705432] |
| MDA-MB-468 | IC50 |
17.48 μM
Compound: 1
|
Cytotoxic activity against human MDA-MB-468 cells incubated for 24 hrs by MTT assay
Cytotoxic activity against human MDA-MB-468 cells incubated for 24 hrs by MTT assay
|
[PMID: 28705432] |
Galiellalactone (2.5-25 μM; 24-72 hour) induces apoptosis of prostate cancer (PCa) cell lines expressingp-Stat3[1].
Galiellalactone (2.5-25 μM; 24-72 hour) decreases viability of DU145 cells[1].
Galiellalactone (10 μM) inhibits STAT3 signaling activity as assessed by luciferase reporter gene assay in IL-6-stimulated LNCaP cells[2].
Galiellalactone (10-100 μM; 1 hour) binds directly to STAT3 in DU145 cells [2].
Galiellalactone (5-50 μM; 1 hour) interferes with STAT3 DNA binding without inhibiting phosphorylation in DU145 cells [2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:DU145, PC-3, and LNCaP cells
-
Concentration:0, 2.5, 5, 10, 25 μM
-
Incubation Time:24, 48, 72 hours
-
Result:Induced an apoptotic response in PC-3 and DU145 cells.
-
Cell Line:DU145 cells
-
Concentration:0, 2.5, 5, 10, 17.5, 25 μM
-
Incubation Time:24, 48, 72 hours
-
Result:Decreased DU145 cells viability in a dose- and time-dependent manner.
-
Cell Line:DU145 cells
-
Concentration:0, 10, 25 μM
-
Incubation Time:48 hours
-
Result:Induced expression of the apoptotic marker cleaved caspase-3 and increased expression of cleaved PARP.
-
Cell Line:DU145 cells
-
Concentration:0, 10, 25, 50, 100 μM
-
Incubation Time:1 hour
-
Result:Prevented the binding of the biotinylated analogue of galiellalactone (GL-biot) to STAT3 in a dose-dependent manner demonstrating competitive binding.
-
Cell Line:DU145 cells
-
Concentration:0, 5, 10, 25, 50 μM
-
Incubation Time:1 hour
-
Result:Inhibited STAT3 binding to DNA in a dose-dependent manner.
Did not affect phosphorylation of STAT3 Tyr-705 and Ser-727 or the expression of total STAT3.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male nude NMR1 mice are injected PCa cell[1]
-
Dosage:0, 1, 3 mg/kg
-
Administration:Daily i.p. injections for 3 weeks
-
Result:Reduced the tumor growth rate in DU145 xenografts by 41-42% and was well tolerated.
Chemical Information
-
CAS No. 133613-71-5
-
Appearance Solid
-
Molecular Weight 194.23
-
Formula C11H14O3
-
Color White to off-white
-
SMILES
O=C1C2=C[C@@H](C)C[C@@]3([H])CC[C@@]([C@@]23O)([H])O1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Purity & Documentation
-
Data Sheet (284 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Hellsten R, et, al. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3. Prostate. 2008 Feb 15; 68(3): 269-80. [Content Brief]
[2]. Doncow DN, et, al. Galiellalactone is a direct inhibitor of the transcription factor STAT3 in prostate cancer cells. J Biol Chem. 2014 Jun 6; 289(23): 15969-78. [Content Brief]
[3]. Weidler M, et, al. Inhibition of interleukin-6 signaling by galiellalactone. FEBS Lett. 2000 Oct 27; 484(1): 1-6. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)